21 March 2017, 06:35 | Joan Schultz
Aratana Therapeutics, Inc. (NASDAQ:PETX) Closed the Last Trading Session at $5.32
Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. At the end of December reporting period, 45 institutional holders increased their position in Aratana Therapeutics, Inc .
Sean Spicer continues to defend President Trump's wiretapping claims
Mr Trump defended his decision to tweet his suspicions without proof because " The New York Times wrote about it". Richard Burr, R-N.C., and Mark Warner, D-Va., said in a one-sentence joint statement Thursday afternoon.
Trump, Tillerson press China for action against North Korea
Last month, Trump and Xi had a telephone conversation that was described as a warm and cordial. Nitze School of Advanced International Studies at Johns Hopkins University in Washington .
Samsung Galaxy S8: Everything You Should Know Ahead of Launch
According to the report , Samsung will include a rear camera on the Galaxy S8 capable of shooting video at 1000 frames per second. Besides these, the site also mentioned the price list of some accessories which can be attributed with both of these handsets.